Welcome to our dedicated page for Edgewell Pers Care Co SEC filings (Ticker: EPC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Edgewell Personal Care Company filings document the financial reporting, governance and capital-structure disclosures of a Missouri-incorporated personal-care company whose common stock trades on the New York Stock Exchange under EPC. Current Reports on Form 8-K furnish quarterly and fiscal-year operating results, non-GAAP earnings materials and Regulation FD updates.
The filing record also covers completed asset-disposition disclosures for the sale of the Feminine Care segment and transition services arrangements related to that transaction. Proxy materials document annual meeting matters, director and executive compensation governance, shareholder voting items and approval of the amended and restated 2018 Stock Incentive Plan.
Edgewell Personal Care Co. (EPC) reported an equity award to its Chief Accounting Officer, John M. Dunham, in a Form 4 filing. On 11/14/2025, he received 3,586 restricted stock equivalents at a price of $0 per unit. These awards are scheduled to vest in three equal installments on 11/14/2026, 11/14/2027, and 11/14/2028, converting into shares of Edgewell common stock as they vest. Vesting requires continued employment on each vesting date, although all or a portion may vest earlier in cases such as death, disability, change in control, or certain termination events.
American Century entities filed a Schedule 13G/A reporting beneficial ownership in Edgewell Personal Care (EPC).
American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research each report 3,950,190 shares, representing 8.5% of Edgewell’s common stock, with sole voting power 3,808,819 and sole dispositive power 3,950,190 as of 09/30/2025. American Century Capital Portfolios, Inc. reports 2,488,777 shares or 5.4%, with sole voting and dispositive power over the same amount.
The filers certify the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Edgewell Personal Care Company furnished an update on its business, announcing financial and operating results for its fourth quarter and fiscal year ended September 30, 2025. The results were disclosed via a press release attached as Exhibit 99.1.
The company noted the information was provided under Item 2.02 and is being furnished, not deemed filed under Section 18 of the Exchange Act, and will not be incorporated by reference into other filings except as expressly stated. The press release was issued on November 13, 2025.
Edgewell Personal Care Company (EPC) entered into an Asset Purchase Agreement to sell its Feminine Care segment to Essity for $340 million in cash, subject to customary adjustments for inventory, indebtedness and other items.
Closing is subject to customary conditions, including required approvals under the HSR Act, no legal restraints, accuracy of representations and warranties, and compliance with covenants. Buyer-specific conditions include no material adverse effect on the business, no ongoing substantial destruction of manufacturing facilities, and certain third‑party consents.
The agreement includes customary termination rights if the deal is not completed by May 12, 2026, with automatic extensions to August 12, 2026 and November 12, 2026 if specified regulatory approvals remain outstanding. The Company may receive a $15 million termination fee from the Buyer under certain circumstances tied to regulatory efforts. The parties expect to enter a transition services agreement at closing.
Edgewell Personal Care (EPC) reported insider transactions by its Chief Supply Chain Officer reflecting RSU vesting and tax withholding over three days. On 11/08/2025, 4,425 shares were acquired at $0 via the conversion of restricted stock equivalents, with 2,051 shares withheld for taxes at $18.83. On 11/10/2025, 2,046 shares were acquired at $0 and 949 shares were withheld at $18.83. On 11/11/2025, 1,635 shares were acquired at $0 and 758 shares were withheld at $18.57.
Following these transactions, direct ownership stood at 43,242.693 shares. The filing notes these were conversions of restricted stock equivalents and that shares were withheld to cover tax liabilities upon vesting.
Edgewell Personal Care (EPC): Chief People & Legal Officer LaTanya Langley reported routine equity award activity. Restricted stock equivalents vested and converted into common stock on three dates: 3,688 shares on 11/08/2025, 2,338 shares on 11/10/2025, and 1,635 shares on 11/11/2025, each at an exercise price of $0.
To cover taxes upon vesting, shares were withheld: 1,835 at $18.83 on 11/08/2025, 1,164 at $18.83 on 11/10/2025, and 814 at $18.57 on 11/11/2025. Following these transactions, the officer directly owned 16,767 shares.
Edgewell Personal Care (EPC) reported an insider transaction by its Chief Accounting Officer. On 11/08/2025, 461 shares of common stock were acquired at $0 upon the vesting and conversion of restricted stock equivalents (code M). To cover taxes, 128 shares were withheld at $18.83 (code F).
Following these transactions, the officer directly owns 333 shares of EPC common stock. Derivative holdings consist of 922 restricted stock equivalents after the reported activity.
Edgewell Personal Care (EPC) CEO and director Rod R. Little reported multiple equity transactions. On 11/08/2025, 11/10/2025, and 11/11/2025, restricted stock equivalents vested and converted to common stock (codes M) for 17,285, 14,612, and 12,578 shares at $0, respectively.
To cover taxes on these vestings (code F), shares were withheld: 8,012 at $18.83 on 11/08/2025, 6,773 at $18.83 on 11/10/2025, and 5,830 at $18.57 on 11/11/2025. Following these transactions, Mr. Little beneficially owned 334,373 shares directly.
Edgewell Personal Care (EPC) CFO reported routine equity transactions on Form 4 tied to restricted stock equivalents vesting. On 11/10/2025, 1,023 shares of common stock were acquired at $0 upon vesting, followed by 356 shares withheld at $18.83 to cover taxes. On 11/11/2025, an additional 780 shares vested at $0, with 272 shares withheld at $18.57 for taxes.
Following these transactions, the CFO directly holds 25,740 shares of EPC common stock. The filing labels the acquisitions as code “M” (conversion of derivative securities) and the withholdings as code “F” (tax withholding), consistent with standard equity award vesting mechanics.
Edgewell Personal Care (EPC): Form 4 insider activity
Officer Jessica Spence, President, North America, reported the vesting and conversion of 4,425 restricted stock equivalents into EPC common stock on 11/08/2025 (Code M) at an exercise price of $0. To satisfy tax obligations, 2,390 shares were withheld (Code F) at a price of $18.83.
Following these transactions, the reporting person directly owns 2,035 shares of EPC common stock. The filing also lists 8,850 derivative securities (restricted stock equivalents) beneficially owned after the reported activity.